Skip to content
News

Aug 01, 2019

Mass Dynamics receives a glowing nod from the City of Melbourne

We are thrilled to have received a glowing nod from the City of Melbourne in the form of a startup grant. We are looking forward to directing the funds towards activities and initiatives that will help put proteomics and mass spectrometry in the hands of more life science researchers who want to accelerate scientific and medical discoveries.

"This year's successful round one recipients represented some of the most innovative small businesses and social enterprises helping to shape Melbourne."
Chair of the Small Business, Retail and Hospitality portfolio, Councillor Susan Riley.

We are thrilled to have received a glowing nod from the City of Melbourne in the form of a startup grant. We are looking forward to directing the funds towards activities and initiatives that will help put proteomics and mass spectrometry in the hands of more life science researchers who want to accelerate scientific and medical discoveries.

CoM - thank you for continuing to help local businesses grow into thriving well-known brands. Melbourne is indeed the place to be!

Full City of Melbourne press release here: https://www.melbourne.vic.gov.au/news-and-media/Pages/More-grants-to-boost-small-businesses.aspx

And more information on City of Melbourne grants here: https://www.melbourne.vic.gov.au/about-council/governance-transparency/Pages/grants-and-sponsorships.aspx 

Dora is our good news megaphone. She draws on decades of marketing and commercial experience across many diverse sectors to help uplift and grow the entire mass spectrometry community.

Latest Articles

Thoughts

It’s not a data problem, it’s a decision problem: 5 tips from Boston’s proteomics leaders

The discussion highlighted the field’s biggest bottlenecks - slow analysis cycles, unclear communication across disciplines, fragmented QC,...

December 10, 2025

Thoughts

Stop Rolling the Dice: Why Proteomics Needs to Move Upstream in Drug Development

The single biggest reason drug discovery fails isn’t safety, financing, or trial execution - it’s biology we didn’t measure. These blind-sp...

August 19, 2025

Thoughts

From Lab Bench to Boardroom: Proteomics Comes of Age

Why now: Proteomics is breaking out of its niche. An unconventional fishbowl forum at ASMS 2025 revealed researchers grappling candidly wit...

June 26, 2025